BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

435 related articles for article (PubMed ID: 27878990)

  • 1. Hemodynamic-guided heart-failure management using a wireless implantable sensor: Infrastructure, methods, and results in a community heart failure disease-management program.
    Jermyn R; Alam A; Kvasic J; Saeed O; Jorde U
    Clin Cardiol; 2017 Mar; 40(3):170-176. PubMed ID: 27878990
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Haemodynamic-guided management of heart failure (GUIDE-HF): a randomised controlled trial.
    Lindenfeld J; Zile MR; Desai AS; Bhatt K; Ducharme A; Horstmanshof D; Krim SR; Maisel A; Mehra MR; Paul S; Sears SF; Sauer AJ; Smart F; Zughaib M; Castaneda P; Kelly J; Johnson N; Sood P; Ginn G; Henderson J; Adamson PB; Costanzo MR
    Lancet; 2021 Sep; 398(10304):991-1001. PubMed ID: 34461042
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Wireless pulmonary artery pressure monitoring guides management to reduce decompensation in heart failure with preserved ejection fraction.
    Adamson PB; Abraham WT; Bourge RC; Costanzo MR; Hasan A; Yadav C; Henderson J; Cowart P; Stevenson LW
    Circ Heart Fail; 2014 Nov; 7(6):935-44. PubMed ID: 25286913
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Wireless pulmonary artery haemodynamic monitoring in chronic heart failure: a randomised controlled trial.
    Abraham WT; Adamson PB; Bourge RC; Aaron MF; Costanzo MR; Stevenson LW; Strickland W; Neelagaru S; Raval N; Krueger S; Weiner S; Shavelle D; Jeffries B; Yadav JS;
    Lancet; 2011 Feb; 377(9766):658-66. PubMed ID: 21315441
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pulmonary Artery Pressure-Guided Management of Patients With Heart Failure and Reduced Ejection Fraction.
    Givertz MM; Stevenson LW; Costanzo MR; Bourge RC; Bauman JG; Ginn G; Abraham WT;
    J Am Coll Cardiol; 2017 Oct; 70(15):1875-1886. PubMed ID: 28982501
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lower Rates of Heart Failure and All-Cause Hospitalizations During Pulmonary Artery Pressure-Guided Therapy for Ambulatory Heart Failure: One-Year Outcomes From the CardioMEMS Post-Approval Study.
    Shavelle DM; Desai AS; Abraham WT; Bourge RC; Raval N; Rathman LD; Heywood JT; Jermyn RA; Pelzel J; Jonsson OT; Costanzo MR; Henderson JD; Brett ME; Adamson PB; Stevenson LW;
    Circ Heart Fail; 2020 Aug; 13(8):e006863. PubMed ID: 32757642
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of Ambulatory Hemodynamic Monitoring of Heart Failure With Clinical Outcomes in a Concurrent Matched Cohort Analysis.
    Abraham J; Bharmi R; Jonsson O; Oliveira GH; Artis A; Valika A; Capodilupo R; Adamson PB; Roberts G; Dalal N; Desai AS; Benza RL
    JAMA Cardiol; 2019 Jun; 4(6):556-563. PubMed ID: 31090869
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Implantable Hemodynamic Monitors Improve Survival in Patients With Heart Failure and Reduced Ejection Fraction.
    Lindenfeld J; Costanzo MR; Zile MR; Ducharme A; Troughton R; Maisel A; Mehra MR; Paul S; Sears SF; Smart F; Johnson N; Henderson J; Adamson PB; Desai AS; Abraham WT;
    J Am Coll Cardiol; 2024 Feb; 83(6):682-694. PubMed ID: 38325994
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preliminary experience with the multisensor HeartLogic algorithm for heart failure monitoring: a retrospective case series report.
    Capucci A; Santini L; Favale S; Pecora D; Petracci B; Calò L; Molon G; Cipolletta L; Bianchi V; Schirripa V; Santobuono VE; La Greca C; Campari M; Valsecchi S; Ammirati F; D'Onofrio A
    ESC Heart Fail; 2019 Apr; 6(2):308-318. PubMed ID: 30632306
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Remote Hemodynamic-Guided Therapy of Patients With Recurrent Heart Failure Following Cardiac Resynchronization Therapy.
    Varma N; Bourge RC; Stevenson LW; Costanzo MR; Shavelle D; Adamson PB; Ginn G; Henderson J; Abraham WT;
    J Am Heart Assoc; 2021 Feb; 10(5):e017619. PubMed ID: 33626889
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Implantable Hemodynamic Monitoring for Heart Failure Patients.
    Abraham WT; Perl L
    J Am Coll Cardiol; 2017 Jul; 70(3):389-398. PubMed ID: 28705321
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The CardioMEMS system in the clinical management of end-stage heart failure patients: three case reports.
    Tschöpe C; Alogna A; Spillmann F; Faragli A; Schmidt G; Blaschke F; Kühl U; Hertel E; Willner M; Morris D; Post H; Noutsias M; Pieske B; Krackhardt F
    BMC Cardiovasc Disord; 2018 Jul; 18(1):155. PubMed ID: 30064356
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ambulatory Hemodynamic Monitoring Reduces Heart Failure Hospitalizations in "Real-World" Clinical Practice.
    Desai AS; Bhimaraj A; Bharmi R; Jermyn R; Bhatt K; Shavelle D; Redfield MM; Hull R; Pelzel J; Davis K; Dalal N; Adamson PB; Heywood JT
    J Am Coll Cardiol; 2017 May; 69(19):2357-2365. PubMed ID: 28330751
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Safety and feasibility of pulmonary artery pressure-guided heart failure therapy: rationale and design of the prospective CardioMEMS Monitoring Study for Heart Failure (MEMS-HF).
    Angermann CE; Assmus B; Anker SD; Brachmann J; Ertl G; Köhler F; Rosenkranz S; Tschöpe C; Adamson PB; Böhm M
    Clin Res Cardiol; 2018 Nov; 107(11):991-1002. PubMed ID: 29777373
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hemodynamic-Guided Heart Failure Management in Patients With Either Prior HF Hospitalization or Elevated Natriuretic Peptides.
    Desai AS; Maisel A; Mehra MR; Zile MR; Ducharme A; Paul S; Sears SF; Smart F; Bhatt K; Krim S; Henderson J; Johnson N; Adamson PB; Costanzo MR; Lindenfeld J;
    JACC Heart Fail; 2023 Jun; 11(6):691-698. PubMed ID: 37286262
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cost/utility ratio in chronic heart failure: comparison between heart failure management program delivered by day-hospital and usual care.
    Capomolla S; Febo O; Ceresa M; Caporotondi A; Guazzotti G; La Rovere M; Ferrari M; Lenta F; Baldin S; Vaccarini C; Gnemmi M; Pinna G; Maestri R; Abelli P; Verdirosi S; Cobelli F
    J Am Coll Cardiol; 2002 Oct; 40(7):1259-66. PubMed ID: 12383573
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hemodynamically-Guided Management of Heart Failure Across the Ejection Fraction Spectrum: The GUIDE-HF Trial.
    Zile MR; Mehra MR; Ducharme A; Sears SF; Desai AS; Maisel A; Paul S; Smart F; Grafton G; Kumar S; Nossuli TO; Johnson N; Henderson J; Adamson PB; Costanzo MR; Lindenfeld J
    JACC Heart Fail; 2022 Dec; 10(12):931-944. PubMed ID: 36456066
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Remote Hemodynamic Monitoring Equally Reduces Heart Failure Hospitalizations in Women and Men in Clinical Practice: A Sex-Specific Analysis of the CardioMEMS Post-Approval Study.
    DeFilippis EM; Henderson J; Axsom KM; Costanzo MR; Adamson PB; Miller AB; Brett ME; Givertz MM
    Circ Heart Fail; 2021 Jun; 14(6):e007892. PubMed ID: 34129363
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Randomized controlled trial of an implantable continuous hemodynamic monitor in patients with advanced heart failure: the COMPASS-HF study.
    Bourge RC; Abraham WT; Adamson PB; Aaron MF; Aranda JM; Magalski A; Zile MR; Smith AL; Smart FW; O'Shaughnessy MA; Jessup ML; Sparks B; Naftel DL; Stevenson LW;
    J Am Coll Cardiol; 2008 Mar; 51(11):1073-9. PubMed ID: 18342224
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Role of Implantable Hemodynamic Monitors to Manage Heart Failure.
    Abraham WT
    Cardiol Clin; 2017 May; 35(2):273-279. PubMed ID: 28411901
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.